【24h】

Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients.

机译:危重病人医院内克雷伯菌菌血症的临床影响。

获取原文
获取原文并翻译 | 示例
       

摘要

In order to determine the clinical impact of Klebsiella bacteremia on critically ill patients, a matched cohort study was conducted between January 1992 and December 2000. During the study period, all intensive care unit (ICU) patients with nosocomial Klebsiella bacteremia were defined as cases ( n=52), but two of these patients were excluded from the matched cohort due to incomplete medical records. The remaining 50 patients were matched at a ratio of 1:2 with control patients ( n=100) on the basis of the APACHE II severity of disease classification system. Patients with Klebsiella bacteremia experienced acute renal failure and hemodynamic instability more often than controls. They also had a longer ICU stay and longer ventilator dependence. In-hospital mortality rates for cases and controls were nearly equal (36% vs. 37%, respectively; P=0.905). In conclusion, after adjusting accurately for severity of underlying disease and acute illness, no difference in mortality was found between ICU patients with Klebsiella bacteremia and their matched control subjects.
机译:为了确定克雷伯菌属菌血症对重症患者的临床影响,于1992年1月至2000年12月进行了一项配对队列研究。在研究期间,将所有院内克雷伯菌属菌血症的重症监护病房(ICU)患者定义为病例( n = 52),但由于医疗记录不完整,其中两名患者被排除在配对队列之外。根据APACHE II疾病分类系统的严重程度,其余50名患者与对照患者(n = 100)的比例为1:2。患有克雷伯菌菌血症的患者比对照组更常发生急性肾功能衰竭和血液动力学不稳定。他们还拥有更长的ICU停留时间和更长的呼吸机依赖性。病例和对照组的院内死亡率几乎相等(分别为36%和37%; P = 0.905)。总之,在对潜在疾病和急性疾病的严重程度进行了准确调整之后,ICU克雷伯菌菌血症患者和相匹配的对照组之间的死亡率没有差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号